1. Executive Summary 2. Introduction 2.1 Overview of Acne 2.1.1 Acne Vulgaris: An Introduction 2.1.2 Acne Vulgaris: Key Facts 2.1.3 Segmentation of Acne Vulgaris 2.1.4 Cause of Acne Vulgaris 2.2 Types of Acne 2.3 Acne Treatment 2.3.1 Classification of Acne Severity 2.3.2 Acne Treatment Continuum 2.3.3 Limitations of Commonly Used Acne Treatments 3. Global Market Analysis 3.1 Global Dermatology Market Analysis 3.1.1 Global Dermatology Market by Value 3.1.2 Global Dermatology Market by Segments (Acne Treatment, Others) 3.2 Global Acne Treatment Market Analysis 3.2.1 Global Acne Treatment Market by Value 3.2.2 Global Acne Treatment Market by Segments (Inflammatory Acne, Non-Inflammatory Acne) 3.2.3 Global Acne Treatment Market by Region (The US, Asia Pacific, ROW) 3.3 Global Acne Treatment Market: Segment Analysis 3.3.1 Global Inflammatory Acne Market by Value 3.3.2 Global Non-Inflammatory Acne Market by Value 4. Regional Analysis 4.1 The US Acne Treatment Market Analysis 4.1.1 The US Acne Treatment Market: Future Outlook 4.1.2 The US Acne Treatment Market: Product Analysis 4.1.3 The US Acne Treatment Market by Value 4.2 Asia Pacific Acne Treatment Market Analysis 4.2.1 Asia Pacific Acne Treatment Market by Value 5. Competitive Landscape 5.1 Global Acne Treatment Market Players by Product Comparison 5.2 The US Acne Treatment Market by Oral Brands 5.3 The US Acne Treatment Market by Topical Brands 5.4 Global Marketed Acne Drugs Competitive Landscape 6. Company Profiles 6.1 Foamix Pharmaceuticals Ltd. 6.1.1 Business Overview 6.1.2 Financial Overview 6.1.3 Business Strategy 6.2 Valeant Pharmaceuticals International, Inc. 6.2.1 Business Overview 6.2.2 Financial Overview 6.2.3 Business Strategy 6.3 Allergan (Actavis Plc) 6.2.1 Business Overview 6.3.2 Financial Overview 6.3.3 Business Strategy 6.4 Nestle (Galderma S.A.) 6.4.1 Business Overview 6.4.2 Business Strategy List of Figures Figure 1: Segmentation of Acne Figure 2: Cause of Acne Vulgaris Figure 3: Types of Acne Figure 4: Classification of Acne Severity Figure 5: Global Dermatology Market by Value; 2015-2017 (US$ Billion) Figure 6: Global Dermatology Market by Value; 2018-2022E (US$ Billion) Figure 7: Global Dermatology Market by Segments; 2017 Figure 8: Global Acne Treatment Market by Value; 2016-2017 (US$ Billion) Figure 9: Global Acne Treatment Market by Value; 2018-2022E (US$ Billion) Figure 10: Global Acne Treatment Market by Segments; 2017 Figure 11: Global Acne Treatment Market by Region; 2017 Figure 12: Global Inflammatory Acne Market by Value; 2017-2022E (US$ Billion) Figure 13: Global Non-Inflammatory Acne Market by Value; 2017-2022E (US$ Billion) Figure 14: The US Acne Treatment Market by Value; 2016-2017 (US$ Billion) Figure 15: The US Acne Treatment Market by Value; 2018-2022E (US$ Billion) Figure 16: Asia Pacific Acne Treatment Market by Value; 2017-2022E (US$ Billion) Figure 17: The US Acne Treatment Market TRx by Oral Brands; 2017 Figure 18: The US Acne Treatment Market TRx by Topical Brands; 2017 Figure 19: Foamix Pharmaceuticals Ltd. Revenue; 2013-2017 (US$ Million) Figure 20: Foamix Pharmaceuticals Ltd. Revenue by Region; 2016 Figure 21: Valeant Pharmaceuticals Revenue; 2013-2017 (US$ Billion) Figure 22: Valeant Pharmaceuticals Revenue by Segments; 2017 Figure 23: Allergan Plc Revenue; 2013-2017 (US$ Billion) Table 1: Acne Vulgaris: Key Facts Table 2: Acne Treatment Continuum Table 3: Limitations of Commonly Used Acne Treatments Table 4: The US Acne Treatment Market - Future Outlook Table 5: Leading Acne Brands; 2016 Table 6: Global Acne Treatment Market Players by Product Comparison Table 7: Global Marketed Acne Drugs Competitive Landscape Table 8: Product Candidate Pipeline